Press Releases | Medtronic

Month Year

Email alerts

Aug 12, 2011

Medtronic to Announce Financial Results for Its First Quarter of the Fiscal Year 2012

MINNEAPOLIS, Aug 12, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the first quarter of its fiscal year 2012 on Tuesday, August 23, 2011....
Aug 5, 2011

Medtronic to Webcast Annual Shareholder Meeting

MINNEAPOLIS, Aug 05, 2011 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live video webcast of the Medtronic Annual Shareholder Meeting on...
Aug 3, 2011

Medtronic Engages Yale University to Oversee Independent, Systematic Reviews of Recombinant Bone Morphogenic Protein-2

First of its Kind Post-Review Website to Provide Scientific Access to Full Clinical Data

MINNEAPOLIS, Aug 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. [NYSE: MDT] announced today that it has provided a grant to Yale University to conduct two fully independent, third-party systematic...
Aug 1, 2011

Medtronic Receives FDA Approval for Advisa DR MRI(TM) SureScan(R) Pacing System Clinical Trial

Investigational Second-Generation Device Reinforces Medtronic's Commitment to Innovative Implantable Cardiac Devices Designed for Use in MRI Environment

MINNEAPOLIS, Aug 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application...
Jul 25, 2011

Medtronic Resolute(R) Drug-Eluting Stent Shows Superiority to Taxus(R) DES in Study of Patients with Coronary Artery Disease

Presented at CVIT by Principal Investigator Shigeru Saito, One-Year Data from RESOLUTE Japan Support Company's PMDA Submission for Product Approval

MINNEAPOLIS, Jul 25, 2011 (BUSINESS WIRE) -- TheResolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), showed superiority to Boston Scientific Corp.'s Taxus(R) DES on the primary...
Jul 21, 2011

Medtronic Announces 2011 "Global Heroes"

Distance Runners from Around the World Who Benefit from Medical Technology to Run Medtronic Twin Cities Marathon Events this Fall

MINNEAPOLIS, Jul 21, 2011 (BUSINESS WIRE) -- Twenty-five long-distance runners who benefit from medical technology will be honored as "Medtronic Global Heroes" when they run the Medtronic Twin...
Jul 11, 2011

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

Patient Enrollment in U.S. Clinical Trial of Renal Denervation with Symplicity(R) Catheter System(TM) for Treating Resistant Hypertension to Start Soon

MINNEAPOLIS, Jul 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY...
Jul 8, 2011

Medtronic Issues Communication about the Potential for Reduced Battery Performance in a Small Percentage of SynchroMed(R) II Implantable Drug Infusion Pumps

Update to July 2009 Letter to Healthcare Professionals

MINNEAPOLIS, Jul 08, 2011 (BUSINESS WIRE) -- As part of its ongoing commitment to keep patients and physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT) is issuing...
Jul 7, 2011

Medtronic To Acquire Salient Surgical Technologies, Inc.

Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader...
Jul 7, 2011

Medtronic To Acquire PEAK Surgical, Inc.

Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire PEAK Surgical, Inc., a recognized leader in the...
Jul 1, 2011

Medtronic Introduces the CD HORIZON(R) Fenestrated Screw Spinal System

Europe first in line to receive Medtronic's innovative product

MEMPHIS, Tenn., Jul 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the European launch of the CD HORIZON(R) Fenestrated Screw Spinal System, which is used in conjunction...
Jun 30, 2011

Medtronic Announces U.S. Launch of New Inflatable Bone Tamp and Syringe System for Treatment of Vertebral Compression Fractures

Kyphon Xpander(TM) II Inflatable Bone Tamp and the Kyphon(R) Inflation Syringe are Latest Innovation in Minimally Invasive Treatment of Spinal Fractures

MEMPHIS, Tenn., Jun 30, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the commercial release of the Kyphon Xpander II Inflatable Bone Tamp (IBT) and the Kyphon Inflation...
Jun 29, 2011

Medtronic Commends Congress and the Institute of Medicine on Study on Advancing Pain Research, Care and Education

MINNEAPOLIS, Jun 29, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today commended the U.S. Congress and the Institute of Medicine (IOM) of the National Academy of Sciences on the release of...
Jun 28, 2011

Medtronic Introduces an Innovative Mobile Application for the CareLink(R) Network

The CareLink(TM) Mobile Application Offers Direct Mobile Access to Data on the Medtronic CareLink(R) Network

MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care...
Jun 28, 2011

Medtronic CEO Omar Ishrak Statement on rhBMP-2 Articles in Spine Journal

MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Following is a statement from Omar Ishrak, chairman and chief executive officer of Medtronic, Inc. (NYSE: MDT) on a series of articles on recombinant...
Jun 25, 2011

Research Presented at ADA Adds to the Clinical Evidence for Medtronic's Sensor-Augmented Insulin Pump Therapy

STAR 3 Continuation Data, Low Glucose Suspend and Patient Reported Outcomes Highlighted at American Diabetes Association's 71st Scientific Sessions

SAN DIEGO, Jun 25, 2011 (BUSINESS WIRE) -- Research presented at the American Diabetes Association's 71st Scientific Sessions (ADA) this week adds to the clinical evidence for Medtronic's...
Jun 23, 2011

Medtronic Board Increases Cash Dividend by Eight Percent; Increases Share Repurchase Plan

MINNEAPOLIS, Jun 23, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an eight percent increase in its cash dividend for fiscal year 2012, raising the...
Jun 18, 2011

VALOR II Study Highlights Strengths of Valiant(R) Thoracic Stent Graft from Medtronic

Innovative Medical Device Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms Through One-Year of Patient Follow-Up in U.S. Clinical Study

MINNEAPOLIS & CHICAGO, Jun 18, 2011 (BUSINESS WIRE) -- An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant(R) Thoracic Stent Graft...
Jun 13, 2011

Company Profile for Medtronic, Inc.

Company Profile for Medtronic, Inc. Jun 13, 2011 (BUSINESS WIRE) -- Medtronic is the global leader in medical technology- alleviating pain, restoring health, and extending life for people with...
Jun 3, 2011

Medtronic CFO Gary Ellis to Speak at Goldman Sachs Healthcare Conference

MINNEAPOLIS, Jun 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual Goldman Sachs...
May 24, 2011

Medtronic Reports Fourth Quarter Earnings

Record Fourth Quarter Revenue of $4.3 Billion Driven by Strong International Growth of 12%

MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 29, 2011. Medtronic recorded fiscal...
May 24, 2011

Medtronic Provides Initial Revenue Outlook and EPS Guidance for Fiscal Year 2012

MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today provided its initial revenue outlook and diluted earnings per share (EPS) guidance for fiscal year 2012. The company...
May 20, 2011

Medtronic Resolute(R) Drug-Eluting Stent Exhibits Strong Safety Profile in Broad Spectrum of Patients

Late-breaker at EuroPCR Confirms Low Rates of Adverse Events with Novel Heart Device in More Than 5,000 Study Subjects

PARIS, May 20, 2011 (BUSINESS WIRE) -- A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong...
May 20, 2011

Positive Clinical Outcomes Reported with Medtronic CoreValve(R) System

Meta-Analysis of Seven International Clinical Registries Presented at EuroPCR 2011 Late-Breaking Presentation

PARIS, May 20, 2011 (BUSINESS WIRE) -- A late-breaking presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 today confirmed positive outcomes in patients receiving the...
May 19, 2011

Study Provides Insight on Medtronic CoreValve(R) System Implants Through Subclavian Approach

New Access for Aortic Valve Replacement Achieves High Procedural Success in Italian Study of High Risk Patients

PARIS, May 19, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve(R) System,...
May 18, 2011

Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

Clinical Data from Multiple Studies Presented at EuroPCR Show Next-Generation Device Delivers Excellent Safety and Efficacy in Challenging Patient Population

PARIS, May 18, 2011 (BUSINESS WIRE) -- For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent (DES) from...
May 17, 2011

Medtronic CoreValve(R) Multi-Center Study Shows Rapid and Sustained Health-Related Quality-of-Life Improvements

Two-year Results from Europe and Canada Represent Longest-term Quality-of-life Assessment of All Transcatheter Aortic Valves to Date

PARIS, May 17, 2011 (BUSINESS WIRE) -- New clinical data presented today at EuroPCR 2011 demonstrate immediate and long-term health-related quality-of-life (HRQoL) benefits for patients receiving...
May 16, 2011

Medtronic Advances Research on Peripheral Devices, Highlights Upcoming Presentations

EuroPCR Program Includes Endovascular Late-Breakers on IN.PACT Drug-Eluting Balloons and Mo.Ma Ultra Embolic Protection System Enrollment in IN.PACT SFA I DEB Study Completed; PIs for IN.PACT SFA II Study Selected

MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. (NYSE: MDT) today announced...
May 16, 2011

Medtronic Launches Quick-to-Dough Bone Cement in the United States

Kyphon(R) Xpede(TM) Bone Cement Is the Latest Offering from Medtronic for Treatment of Spinal Fractures

MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of Kyphon Xpede Bone Cement, a quick-to-dough polymethylmethacrylate (PMMA) bone cement for...
May 13, 2011

Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year Ended April 29, 2011

MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year end 2011 on Tuesday, May 24, 2011....
May 13, 2011

Vertebral Augmentation for Spinal Fractures Continues to Be Covered by Noridian Administrative Services

Kyphon(R) Balloon Kyphoplasty is Among Treatments that Continue to be Covered by Major Medicare Administrative Contractor

MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that Noridian Administrative Services, a major Medicare Administrative Contractor providing Medicare...
May 12, 2011

Medtronic to Release New Clinical Data on Unrivaled Portfolio of Interventional Devices at EuroPCR

Highlights Include Late-Breakers and Other Scientific Sessions on CoreValve System, Resolute Drug-Eluting Stent, IN.PACT Drug-Eluting Balloons, Mo.Ma Embolic Protection System, and Renal Denervation with Symplicity Catheter System

MINNEAPOLIS, May 12, 2011 (BUSINESS WIRE) -- New clinical data on a range of innovative medical devices from Medtronic, Inc. (NYSE: MDT), to treat cardiac and vascular diseases - from severe...
May 10, 2011

Medtronic Board of Directors Announces Appointment of Omar Ishrak as Chairman and CEO

MINNEAPOLIS, May 11, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) announced today that its board of directors named Omar Ishrak as the company's new chairman and chief executive officer,...
May 9, 2011

Medtronic and Bayer HealthCare Expand International Alliance

MINNEAPOLIS & TARRYTOWN, N.Y., May 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Bayer HealthCare have expanded their international alliance to now include the United States and will...
May 5, 2011

Medtronic's Reveal(R) XT Insertable Cardiac Monitor Helps Determine AF Burden in Symptomatic and Asymptomatic Patients Following RF Ablation

MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced findings from the DISCERN AF trial, which utilized Medtronic's Reveal(R) XT insertable...
May 5, 2011

New Data Shows Clinical Benefit of Cardiac Resynchronization Therapy (CRT) in Atrial Fibrillation (AF)

Results Provide Evidence Supporting Potential Expansion of Indications for CRT in Symptomatic, Permanent Atrial Fibrillation Patient Population

MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Data presented as a Late Breaking Clinical Trial at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions,...
May 5, 2011

Medtronic Announces FDA Approval of Attain Ability(R) Plus and Attain Ability(R) Straight Left-Heart Leads for Cardiac Resynchronization Therapy (CRT) Devices

New Leads Add to Company's Expansive Portfolio of Innovative CRT-Related Technology Proven to Treat Heart Failure Patients

MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the Attain Ability(R)...
May 3, 2011

Physio-Control Introduces New Hospital Solutions for the LIFEPAK 15 Monitor/Defibrillator

New Feature Set Includes External AC/DC Power and Temperature Monitoring for Therapeutic Hypothermia Patients

REDMOND, Wash., May 03, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), today announced...
May 2, 2011

Medtronic Announces FDA Clearance and First Patient Procedure with the Achieve(TM) Mapping Catheter

New Technology Adds Diagnostic Capability to the Arctic Front(R) Cardiac CryoAblation Catheter System in Treating Paroxysmal Atrial Fibrillation

MINNEAPOLIS, May 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval for use, and the first patient procedure using the...
Apr 27, 2011

Medtronic Announces Date for 2011 Annual Meeting

Shareholders Invited to Attend Annual Meeting on Aug. 25, 2011

MINNEAPOLIS, Apr 27, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT), today announced that the company's annual meeting of shareholders will be held at 10:30 a.m.,...
Apr 20, 2011

Medtronic Teams with Medical Device Recipient in English Channel Swim

Artificial Disc Recipient to Raise Funds for ALS Research

MEMPHIS, Tenn., Apr 20, 2011 (BUSINESS WIRE) -- In August 2011, Doug McConnell of Barrington, Illinois, expects to be the 48th person over age 50 to successfully swim across the English Channel....
Apr 19, 2011

Medtronic Introduces the MARROWMAX(TM) Bone Marrow Aspiration Needle Kit

Product complements Medtronic's Biologics and bone grafting portfolio

MEMPHIS, Tenn., Apr 19, 2011 (BUSINESS WIRE) -- Expanding its leading bone grafting portfolio, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the MARROWMAX(TM) Bone Marrow...
Apr 18, 2011

Medtronic Launches New, Enhanced Midas Rex e-Institute(R) Website for Residents, Surgeons, and Healthcare Staff

New Site Offers Unrestricted Access to Interactive Learning

MINNEAPOLIS, Apr 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced the launch of its new Midas Rex e-Institute(R) website (www.e-institute.com), an enhanced web portal for...
Apr 11, 2011

Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Contro

Enlite(TM) SensorAvailable to Diabetes Patients for Continuous Glucose Monitoring in More Than 35 Countries

MINNEAPOLIS, Apr 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite(TM) Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring...
Apr 7, 2011

Medtronic to Form a Single, Unified U.S. Cardiac and Vascular Group Sales Organization

New Structure Uniquely Positions Medtronic to Maintain Focus on Clinicians While Addressing the Needs of Cardiac and Vascular-focused Hospital Administrators

MINNEAPOLIS, Apr 07, 2011 (BUSINESS WIRE) -- Responding to the challenges hospitals face in the changing healthcare environment, as well as the increasing importance of the hospital administrator...
Apr 4, 2011

Medtronic Resolute(R) Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

Across Spectrum of Patients with Coronary Artery Disease, Novel Heart Device Shows Strong Results at One Year in RESOLUTE US and Two Years in RESOLUTE All Comers

NEW ORLEANS, Apr 04, 2011 (BUSINESS WIRE) -- Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology (ACC) -...
Apr 4, 2011

Medtronic Announces Mac Compatibility for CareLink(R) Personal Therapy Management Software for Diabetes

Software Helps Users Identify Low and High Glucose Levels

MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval and the market launch of CareLink(R) Personal 5.4 Therapy Management...
Apr 4, 2011

Landmark IMPROVE HF Study Shows Adherence to Outpatient Quality Measures Associated with Improved Survival in Heart Failure Patients

Study Published Today in Circulation is the First to Assess the Correlation of Seven Heart Failure Process-Based Quality Measures with Clinical Outcomes

MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Results from the largest U.S. outpatient heart failure clinical study, published today in the journal Circulation and funded by Medtronic, Inc. (NYSE:...
Apr 1, 2011

Medtronic Announces FDA Approval of InterStim(R) Therapy for Bowel Control

Unique Sacral Nerve Stimulation Therapy Now Available for Treatment of Chronic Fecal Incontinence

MINNEAPOLIS, Apr 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of InterStim(R) Therapy for Bowel Control. InterStim...
Mar 28, 2011

Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11

Late-Breaking Clinical Trials Feature One-Year Results of RESOLUTE US Study; Latest Evidence from Comprehensive Research Program Completes FDA Approval Submission

MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced the imminent release of the pivotal U.S. data on its Resolute(R) drug-eluting stent (DES) at ACC.11, the 60th
Mar 28, 2011

Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks

New Implantable Cardiac Devices with SmartShock(TM) Technology Enhance Patient Quality of Life

MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta(TM)portfolio of implantable...
Mar 24, 2011

Medtronic Announces FDA Approval of Consulta(R) and Syncra(TM) Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Systems

CRT Innovation is the First to Offer Exclusive OptiVol(R) Fluid Status Monitoring with Complete Remote Follow-Up for Proactive Heart Failure Management

MINNEAPOLIS, Mar 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food & Drug Administration (FDA) has approved its Consulta(R) and Syncra(TM) cardiac...
Mar 16, 2011

Medtronic Announces Launch of Activa(R) SC Deep Brain Stimulation System

Single-Channel Device Completes Medtronic's Advanced Activa(R) Therapy Portfolio for Patients with Movement Disorders

MINNEAPOLIS, Mar 16, 2011 (BUSINESS WIRE) -- With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation (DBS) therapy, Medtronic, Inc. (NYSE: MDT) today announced...
Mar 14, 2011

Medtronic Announces Global Launch of New Heart Valve Repair Ring Designed to Adapt to Heart's Natural Valve

NewRemodeling Ring Enhances Medtronic's Surgical Heart Valve Repair Portfolio

MINNEAPOLIS, Mar 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour...
Mar 14, 2011

Medtronic Pledges $1 Million to Relief Efforts in Japan

MINNEAPOLIS, Mar 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that it is pledging a total of $1 million (U.S.) in direct grants, employee matching grants and product...
Mar 11, 2011

Medtronic CFO Gary Ellis to Speak at Barclays Capital 2011 Global Healthcare Conference

MINNEAPOLIS, Mar 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the annual Barclays Capital 2011...
Mar 10, 2011

Medtronic Introduces the ATLANTIS VISION(R) ELITE Anterior Cervical Plate System

Offering Surgeons A New Plate Design To Treat The Cervical Spine

MEMPHIS, Tenn., Mar 10, 2011 (BUSINESS WIRE) -- Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the ATLANTIS...
Mar 10, 2011

Medtronic Announces Public Offering of Senior Notes

MINNEAPOLIS, Mar 10, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $500 million of its 2.625% Senior Notes due 2016 and $500 million of its 4.125%...
Mar 10, 2011

Medtronic Introduces VERTEX SELECT(R) CHROMALOY(TM) Plus Rods

Offering Surgeons An Additional Rod Material Option To Treat The Occipitocervical and Upper-Thoracic Spine

MEMPHIS, Tenn., Mar 10, 2011 (BUSINESS WIRE) -- Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of VERTEX...
Mar 9, 2011

Medtronic Resolves FDA Warning Letters

MINNEAPOLIS, Mar 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning...
Mar 9, 2011

Medtronic Inaugurates Its New State-of-the-Art Manufacturing Facility in Singapore

Facility established to meet the increase in demand for high quality cardiac devices in Asia

SINGAPORE, Mar 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc., the global medical technology leader, announced today the official opening of its new manufacturing facility, Medtronic Singapore...
Mar 8, 2011

Medtronic CareLink(R) Network Remote Monitoring Helps Improve Patient Care and Reduce Healthcare Costs

CONNECT Trial Demonstrates Clinical and Economic Benefits of Remote Monitoring in Reducing Hospital Stays and In-Office Visits for Cardiac Patients Treated with Implantable Devices

MINNEAPOLIS, Mar 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced results from a clinical trial that showed remote monitoring of implantable cardiac device patients with the...
Mar 8, 2011

Medtronic Inaugurates Its New Regional Headquarters Building in Greater China

Facility established to support further localization in the region

SHANGHAI, Mar 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc., the global medical technology leader, announced today the official opening of its new regional headquarters building in Shanghai, China....
Mar 4, 2011

Medtronic Announces European Launch of Achieve(TM) Mapping Catheter

Innovative Technology Designed to Optimize Arctic Front(R) Cardiac CryoAblation Catheter System in the Treatment of Paroxysmal Atrial Fibrillation

MINNEAPOLIS & TOLOCHENAZ, Switzerland, Mar 04, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the European launch of the Achieve(TM) Mapping Catheter, an intra-cardiac...
Mar 3, 2011

Expert Panel Publishes Findings on Benefits of Underutilized Intrathecal Baclofen Therapy for Severe Spasticity in Multiple Sclerosis Patients

Consensus Paper Suggests Medtronic ITB Therapy is an Effective Treatment for Control of Severe Spasticity, a Frequent and Disabling Symptom of MS

MINNEAPOLIS, Feb 03, 2011 (BUSINESS WIRE) -- A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and...
Mar 3, 2011

Medtronic Foundation Commits $15 Million in Unprecedented Effort to Reduce Sudden Cardiac Arrest Deaths

HeartRescue Project is first multi-state effort to systemically tackle one of nation's leading killers

MINNEAPOLIS, Mar 03, 2011 (BUSINESS WIRE) -- The Medtronic Foundation announced today a $15 million commitment to reduce sudden cardiac arrest deaths in the United States. The HeartRescue Project...
Mar 3, 2011

Medtronic Seeking Long-Distance Runners Who Benefit from Medical Technology

"Global Heroes" Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October

MINNEAPOLIS, Mar 03, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the sixth...
Mar 2, 2011

Medtronic Answers United Nations' Call for "International Commitment" to Non-Communicable Diseases

MINNEAPOLIS, Mar 02, 2011 (BUSINESS WIRE) -- In its continued commitment to reduce the global burden of non-communicable diseases (NCDs), Medtronic, Inc. today announced it will make nearly $4...
Feb 28, 2011

Medtronic Mosaic(R) Heart Valve Demonstrates Long-Term Durability up to 12 Years in International Study

MINNEAPOLIS, Feb 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that its Mosaic(R) bioprosthetic heart valve has demonstrated positive performance results at 12 years in a...
Feb 25, 2011

Medtronic Announces Purchase of Innovative Gel Technology for Potential Use in Functional Endoscopic Sinus Surgery (FESS)

MINNEAPOLIS, Feb 25, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research &...
Feb 24, 2011

Medtronic CEO William Hawkins to Speak at Citi 2011 Global Healthcare Conference

MINNEAPOLIS, Feb 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the annual Citi 2011 Global...
Feb 20, 2011

Medtronic Reports Third Quarter Earnings

Revenue of $4.0 Billion Grew 3% on Strength of New Products

MINNEAPOLIS, Feb 22, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2011, which ended January 28, 2011. The company...
Feb 18, 2011

Largest Study of Medtronic CoreValve(R) System Confirms Positive Clinical Outcomes

CoreValve Italian Registry Results Demonstrate Clinical Benefits in a Real-World Patient Population

MINNEAPOLIS, Feb 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today issued a statement on results from an independent study published online in the journal Circulation, which confirmed...
Feb 17, 2011

Two-Year Study Continues to Demonstrate Benefits of Kyphon(R) Balloon Kyphoplasty Compared with Non-Surgical Care in Treating Spinal Fractures

Advantages of Kyphon Balloon Kyphoplasty Include Better Back Pain Relief and Quality of Life, with Higher Patient Satisfaction, Study Shows

MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT), announced today thattwo-year data from the largest multicenter randomized controlled study of Kyphon Balloon Kyphoplasty...
Feb 17, 2011

CORRECTING and REPLACING Two-Year Study Continues to Demonstrate Benefits of Kyphon(R) Balloon Kyphoplasty Compared with Non-Surgical Care in Treating Spinal Fractures

Advantages of Kyphon Balloon Kyphoplasty Include Better Back Pain Relief and Quality of Life, with Higher Patient Satisfaction, Study Shows

MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: TWO-YEAR STUDY CONTINUES TO...
Feb 17, 2011

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2011

MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock. The dividend is...
Feb 16, 2011

FDA Classifies Labeling Corrections Related to Occurrence of Pocket Fills During a SynchroMed(R) Implantable Infusion Pump Refill as a Class I Recal

MINNEAPOLIS, Feb 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has classified the corrections being made to product...
Feb 16, 2011

Kyphon(R) Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients

Study Showed Minimally Invasive Procedure Provided Better Back Function, More Rapid Back Pain Relief and Improved Quality of Life Compared with Non-surgical Care

MINNEAPOLIS, Feb 16, 2011 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT) today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with...
Feb 14, 2011

Medtronic to Announce Financial Results for the Third Quarter of Fiscal Year 2011

MINNEAPOLIS, Feb 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2011 on Tuesday, February 22,...
Feb 9, 2011

Physio-Control and BeneChill Partner to Bring Portable Therapeutic Hypothermia Solution to Market

Companies to launch RhinoChill Intranasal Cooling System in Europe and jointly develop future potential solutions

REDMOND, Wash. & SAN DIEGO, Feb 09, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT) and...
Feb 9, 2011

Court Confirms Globus Device Infringes Medtronic Patents

MEMPHIS, Tenn., Feb 09, 2011 (BUSINESS WIRE) -- Medtronic (NYSE:MDT) announced today that the United States Court of Appeals for the Federal Circuit affirmed that the Pivot system offered by...
Feb 8, 2011

Medtronic Receives FDA Approval for First and Only Pacemaker System in the U.S. Designed for Use in the MRI Environment

Revo MRI(TM) SureScan(R) Pacing System Offers Pacemaker Patients Access to MRI Scans

MINNEAPOLIS, Feb 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved its Revo MRI(TM) SureScan(R) pacing system, the...
Feb 8, 2011

Medtronic Issues Statement on District Court Ruling Regarding CoreValve

MINNEAPOLIS, Feb 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. District Court of Delaware issued its ruling on post-trial motions filed by the parties in...
Feb 4, 2011

Medtronic: Expert Panel Publishes Findings on Benefits of Underutilized Intrathecal Baclofen Therapy for Severe Spasticity in Multiple Sclerosis Patients

Consensus Paper Suggests Medtronic ITB Therapy is an Effective Treatment for Control of Severe Spasticity, a Frequent and Disabling Symptom of MS

MINNEAPOLIS, Feb 04, 2011 (BUSINESS WIRE) -- A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and...
Jan 27, 2011

Medtronic Announces Global Launch of the CD HORIZON(R) SOLERA(TM) Spinal System

Latest innovation in technology offers new capabilities for surgeons, hospitals and their patients

MEMPHIS, Tenn., Jan 27, 2011 (BUSINESS WIRE) -- Continuing a stream of recent advancements for stabilization of the spine, Medtronic, Inc. (NYSE: MDT) today announced both the release of its CD...
Jan 18, 2011

Medtronic Revises Design ofCoreValve(R) U.S. Pivotal Trial

Inoperable Patients Will Be Evaluated in Single Arm Study, Not Randomized to Medical Management

MINNEAPOLIS, Jan 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to modify its...
Jan 13, 2011

Medtronic Completes Acquisition of Ardian

Interventional Therapy Addresses Uncontrolled Hypertension with Renal Denervation

MINNEAPOLIS & MOUNTAIN VIEW, Calif., Jan 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced that it has completed the acquisition of privately-held Ardian, Inc., a developer...
Jan 7, 2011

Medtronic CEO William Hawkins to Speak at J.P. Morgan Healthcare Conference

MINNEAPOLIS, Jan 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 29th annual J.P. Morgan...
Jan 5, 2011

Medtronic Announces $750,000 in Funding to Support Healthcare Infrastructure Development in Haiti

Grants to Partners In Health and International Medical Corps fulfill commitment made following the 2010 earthquake

MINNEAPOLIS, Jan 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today $750,000 in grants through the Medtronic Foundation to support continued healthcare infrastructure...
Jan 3, 2011

Medtronic CEO William Hawkins to Speak at Goldman Sachs Healthcare CEO Conference

MINNEAPOLIS, Jan 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Goldman Sachs Healthcare CEOs...
Dec 21, 2010

Med-Tech Advance for 'Silent Killer': FDA Approves Medtronic Device to Fix Abdominal Aortic Aneurysms

Endurant(R) AAA Stent Graft Expands Patient Access to Minimally Invasive Procedure To Repair Dangerous Bulge in Body's Main Artery Without Major Surgery

MINNEAPOLIS, Dec 21, 2010 (BUSINESS WIRE) -- An estimated 1.2 million people in the United States have an abdominal aortic aneurysm (AAA) - a dangerous bulge or ballooning in their bodies' main...
Dec 21, 2010

Landmark Medtronic CoreValve(R) U.S. Clinical Trial Begins

Investigational Therapy Offers Treatment Alternative to Open Heart-Surgery for Patients with Severe Aortic Stenosis

MINNEAPOLIS, Dec 21, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the beginning of its Medtronic CoreValve(R) U.S. Pivotal clinical trial in the United States. The first...
Dec 20, 2010

Medtronic Announces Chairman and CEO William A. Hawkins to Retire at End of Company's Current Fiscal Year

MINNEAPOLIS, Dec 20, 2010 (BUSINESS WIRE) -- Medtronic (NYSE:MDT) announced today that William A. Hawkins intends to retire as Chairman and CEO of Medtronic at the conclusion of the current fiscal...
Dec 17, 2010

Medtronic Receives FDA Approval for First and Only Cryoballoon Ablation Treatment in the U.S. for Paroxysmal Atrial Fibrillation

New Arctic Front(R) Cardiac CryoAblation Catheter System Reduces Symptoms for Patients with Common Heart Rhythm Disorder

MINNEAPOLIS, Dec 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic Front(R) Cardiac CryoAblation...
Dec 9, 2010

Medtronic CoreValve(R) System Gains CE Mark for New Subclavian Approach to Transcatheter Aortic Valve Implantation

Approval is Expected to Expand Access to Care for Patients with Severe Aortic Stenosis

MINNEAPOLIS, Dec 09, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) has received CE (Conformité Européenne) Mark for the Medtronic CoreValve(R) System to be delivered through a novel...
Dec 9, 2010

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2011

MINNEAPOLIS, Dec 09, 2010 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock. The dividend is...
Dec 2, 2010

Medtronic Announces CD HORIZON(R) System 510k Pedicle Screw Clearance for Adolescent Idiopathic Scoliosis

New Indication Will Help Advance Spine Care and Research for Children

MEMPHIS, Tenn., Dec 02, 2010 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it received clearance to treat adolescent idiopathic scoliosis (AIS). This marks the first such clearance by...
Dec 2, 2010

European Economic Analysis Shows Cost Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients

New Findings from Sub-Analysis of REVERSE Trial Published in the European Heart Journal

MINNEAPOLIS, Dec 02, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left...
Nov 29, 2010

Medtronic Presents One-Year Data on Endurant(R) Stent Graft

Definitive Results from U.S. IDE Study Demonstrate Durable Safety and Effectiveness of Implantable Medical Device for Minimally Invasive Treatment of Abdominal Aortic Aneurysms

MINNEAPOLIS & NEW YORK, Nov 19, 2010 (BUSINESS WIRE) -- An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms, the Endurant(R) Stent Graft System...
Nov 29, 2010

Medtronic Reports Second Quarter Earnings

International Revenue of $1.6 Billion Grew 6% on a Constant Currency Basis; 4% As Reported

MINNEAPOLIS, Nov 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2011, which ended October 29, 2010. The company...

Show per page